PETER MANNON, M.D.
Osteopathic Medicine at 19 St, Birmingham, AL

License number

Alabama 29024

Personal information

See more information about PETER MANNON at radaris.com

Name

Address

Phone

Peter Mannon, age 65

3112 Pine Ridge Rd, Mountain Brk, AL 35213

(205) 423-0311

Peter J Mannon, age 65

3112 Pine Ridge Rd, Birmingham, AL 35213

(205) 423-0311

Organization information

See more information about PETER MANNON at bizstanding.com

Peter Mannon MD

2000 6 Ave S, Birmingham, AL 35233

Industry:

Internist

Phone:

(800) 822-8816 (Phone)

Peter Joseph Mannon

Professional information

See more information about PETER MANNON at trustoria.com

Dr. Peter Mannon, Birmingham AL - MD (Doctor of Medicine)

Specialties:

Gastroenterology

Address:

University of Alabama GAS
1808 7Th Ave S SUITE 380, Birmingham 35233
(205) 934-6060 (Phone)

Certifications:

Gastroenterology, 1989, Internal Medicine, 1986

Awards:

Healthgrades Honor Roll

Languages:

English, Spanish

Hospitals:

University of Alabama GAS
1808 7Th Ave S SUITE 380, Birmingham 35233
University of Alabama Hospital
1802 6Th Ave South, Birmingham 35233
Uab Highlands
1201 11Th Ave South, Birmingham 35205

Education:

Medical School
Boston University School Of Medicine
Graduated: 1983
Duke University Med Center
Graduated: 1984
Graduated: 1986
Johns Hopkins Hospital

Peter J Mannon, Birmingham AL

Specialties:

Gastroenterologist

Address:

University Of Alabama At Birmingham, Birmingham, AL 35294
619 19Th St S, Birmingham, AL 35249

Education:

Boston University, School of Medicine - Doctor of Medicine
Johns Hopkins Hospital - Fellowship - Gastroenterology (Internal Medicine)
Duke University Hospital - Residency - Internal Medicine

Board certifications:

American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Gastroenterology (Internal Medicine)

Use Of Muramyl Dipeptide (Mdp) For Treating Inflammation

US Patent:

8603978, Dec 10, 2013

Filed:

Nov 30, 2007

Appl. No.:

12/516633

Inventors:

Warren Strober - Bethesda MD, US
Ivan Fuss - Kensington MD, US
Atsushi Kitani - Rockville MD, US
Peter Mannon - Birmingham AL, US
Tomohiro Watanabe - Kyoto, JP

Assignee:

The United States of America, as represented by the Secretary, Department of Health and Humand Services - Washington DC

International Classification:

A61K 38/00, A61P 1/04

US Classification:

514 132

Abstract:

The present invention provides a method of treating or preventing inflammation in a subject comprising administering to the subject an effective amount of a muramyl dipeptide (MDP).

Treatment Of Cancer Via Targeting Of Il-13 Receptor-Alpha2

US Patent:

2011026, Nov 3, 2011

Filed:

Jul 31, 2008

Appl. No.:

12/671652

Inventors:

Warren Strober - Bethesda MD, US
Jay A. Berzofsky - Bethesda MD, US
Stefan Fichtner-Feigl - Mainburg, DE
Atsushi Kitani - Rockville MD, US
Ivan J. Fuss - Bethesda MD, US
Masaki Terabe - Bethesda MD, US
Peter Mannon - Birmingham AL, US

Assignee:

The Government of the US as Represented by the Secretary Department of Health and Human Services - Rockville MD

International Classification:

A61K 39/395, A61K 31/7088, A61P 35/00, A61K 38/17

US Classification:

4241741, 514 193, 514 198, 514 44 R

Abstract:

Disclosed herein are compositions and methods for treating or preventing cancer involving the use of a TNF-alpha antagonist, an IL-13Rαantagonist, and/or a AP-I antagonist.